Patents by Inventor Gary Goodson

Gary Goodson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS OF L-ORNITHINE PHENYLACETATE
    Publication number: 20220184014
    Abstract: Some embodiments of the present application are directed to oral formulations of L-ornithine phenylacetate and methods of preparing the same. These oral formulations offer alternative administration route than the standard intravenous administration of L-ornithine phenylacetate for treating hyperammonemia in patients having various acute and chronic liver diseases and disorders, for example, acute liver failure, liver cirrhosis, liver decompensation, portal hypertension, hepatic encephalopathy, or patients with urea cycle disorders.
    Type: Application
    Filed: December 22, 2021
    Publication date: June 16, 2022
    Inventors: Kenneth Ruettimann, Mark Coffin, James Bernstein, Gary Goodson, Laurene Wang
  • FORMULATIONS OF L-ORNITHINE PHENYLACETATE
    Publication number: 20160338982
    Abstract: Some embodiments of the present application are directed to oral formulations of L-ornithine phenylacetate and methods of preparing the same. These oral formulations offer alternative administration route than the standard intravenous administration of L-ornithine phenylacetate for treating hyperammonemia in patients having various acute and chronic liver diseases and disorders, for example, acute liver failure, liver cirrhosis, liver decompensation, portal hypertension, hepatic encephalopathy, or patients with urea cycle disorders.
    Type: Application
    Filed: April 19, 2016
    Publication date: November 24, 2016
    Inventors: Kenneth Ruettimann, Mark Coffin, James Bernstein, Gary Goodson, Laurene Wang
  • Compositions comprising triptans and nsaids
    Publication number: 20070184109
    Abstract: A pharmaceutical composition comprising 5HT1 receptor agonist or a pharmaceutically acceptable derivative thereof in combination with an NSAID or pharmaceutically acceptable derivative thereof wherein the 5HT1 receptor agonist and NSAID are located in discrete zones with respect to each other wherein each zone comprises the active ingredient and optionally a carrier. A preferred composition comprises sumatriptan succinate and naproxen sodium.
    Type: Application
    Filed: June 2, 2004
    Publication date: August 9, 2007
    Inventors: Alison Floyd, Cecilia Navy, Gary Goodson
  • Pharmaceutical compositions
    Publication number: 20050287177
    Abstract: A pharmaceutical composition comprising 3?-azido-3?-deoxythymidine and (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one suitable for once daily administration
    Type: Application
    Filed: November 7, 2003
    Publication date: December 29, 2005
    Applicant: Glaxo Group Unlimited and Smithkline Beecham Corp.
    Inventors: Gary Goodson, Alison Floyd, Cecilia Navy
  • Pharmaceutical compositions comprising abacavir and lamivudine
    Publication number: 20050171127
    Abstract: A pharmaceutical composition comprising (1S,cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol and (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one, in an amount which achieves antiviral efficacy, a process for the preparation of such a composition, and a method of inhibiting human immunodeficiency virus (HIV) which comprises administering such a composition to an HIV infected patient is disclosed.
    Type: Application
    Filed: June 3, 2003
    Publication date: August 4, 2005
    Inventors: Robin Currie, Gary Goodson
  • Pharmaceutical compositions
    Publication number: 20050113394
    Abstract: A pharmaceutical composition comprising (1S, cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol in an amount which achieves antiviral efficacy, a process for the preparation of such a composition, and a method of inhibiting human immunodeficiency virus (HIV) which comprises administering such a composition to an HIV infected patient is disclosed.
    Type: Application
    Filed: November 24, 2004
    Publication date: May 26, 2005
    Inventors: Allen Wood, Robin Currie, Samir Mehta, Gary Goodson, Mickey Wells
  • Novel formulations and method of treatment
    Publication number: 20050032799
    Abstract: A sustained release formulation of lamotrigine or a pharmaceutically acceptable derivative thereof and methods of treatment and uses thereof.
    Type: Application
    Filed: July 29, 2003
    Publication date: February 10, 2005
    Inventors: Ian Buxton, Robin Currie, Myrna Dela-Cruz, Gary Goodson, Wlodzimierz Karolak, Mehran Maleki, Vijay Iyer, Gopal Muppirala, Alan Parr, Jagdev Sidhu, Robert Stagner, Akunuri Vijay-Kumar